// App-Quantinova.ai

POS0277 (2022) : EFFECT OF COLCHICINE THERAPY ON ATHEROSCLEROSIS-RELATED CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CALCIUM PYROPHOSPHATE CRYSTAL DEPOSITION DISEASE

Researchers

Presenter

  • E. Cheremushkina

Principal Investigators

  • M. Eliseev

  • O. Sheliabina

  • A. Novikova

  • S. Glukhova

Medical Centers

  • VA Nasonova Research Institute of Rheumatology, Laboratory Axial Spondyloarthritis, Moscow, Russian Federation

  • Lapino Clinical Hospital, Rheumatology, Lapino, Russian Federation

  • VA Nasonova Research Institute of Rheumatology, Laboratory Axial Spondyloarthritis, Moscow, Russian Federation

Locations

  • Russia

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Cardiovascular (CVS)

  • Musculoskeletal

  • Endocrine/metabolic Diseases (ME)

Disease

  • Myocardial infarction

  • Coronary Artery Disease

  • Diabetes

  • Osteoarthritis

  • Congestive heart failure

  • Hypercalcaemia

  • Hypertension

  • Inflammatory Arthritis

Biomarkers

  • C reactive protein

  • Body mass index

Drug/Treatment

  • Parathyroid hormone

  • Hydroxychloroquine

  • Glucocorticoid

  • Methotrexate

  • Colchicine

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved